Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
Operating Income
Theralase Technologies Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Theralase Technologies Inc
XTSX:TLT
|
Operating Income
-CA$4.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-15%
|
|
Neovasc Inc
TSX:NVCN
|
Operating Income
-$33.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-21%
|
|
Profound Medical Corp
TSX:PRN
|
Operating Income
-$28.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
Opsens Inc
TSX:OPS
|
Operating Income
-CA$12.5m
|
CAGR 3-Years
-86%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
-19%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Operating Income
-CA$10.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
MedMira Inc
XTSX:MIR
|
Operating Income
-CA$2.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-8%
|
CAGR 10-Years
3%
|
See Also
What is Theralase Technologies Inc's Operating Income?
Operating Income
-4.6m
CAD
Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Operating Income amounts to -4.6m CAD.
What is Theralase Technologies Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-15%
Over the last year, the Operating Income growth was 12%. The average annual Operating Income growth rates for Theralase Technologies Inc have been 7% over the past three years , -6% over the past five years , and -15% over the past ten years .